Table 4.
Comparison of long-term outcomes and patient-reported outcomes between the two groups
| Index | Traditional group n = 43 | Modified group n = 37 | Statistics | P |
|---|---|---|---|---|
| Spasm Recurrence (n, %) | 3 (7.0%) | 1 (2.7%) | 0.721 (Fisher’s) | 0.348 |
| Persistent Mild Facial Weakness (HB II) (n, %) | 2 (4.7%) | 1 (2.7%) | 0.270 (Fisher’s) | 0.603 |
| Patient Satisfaction (Very Satisfied/Satisfied) (n, %) | 37 (86.0%) | 35 (94.6%) | 1.769 (χ2) | 0.184 |
| Postoperative Pain (VAS at 7 days, mean ± SD) | 3.6 ± 1.1 | 2.8 ± 0.9 | 3.215 (t) | 0.002 |
HB IIHouse-Brackmann Grade II, VAS Visual Analog Scale
P-values for categorical data calculated using Fisher's exact test or χ2 test as appropriate. P-value for VAS calculated using Student's t-test